NCT05579730: A trial that was reported late by Bausch & Lomb Incorporated
This trial has reported, although it was 10 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05579730 |
|---|---|
| Title | Evaluation of Combination Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution Compared to Its Components and Vehicle for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge Model |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 12, 2022 |
| Completion date | July 22, 2023 |
| Required reporting date | July 21, 2024, midnight |
| Actual reporting date | Aug. 1, 2024 |
| Date last checked at ClinicalTrials.gov | May 29, 2026 |
| Days late | 10 |